Tomokazu Nagano

Statistics

Publications

Citations

887

H-Index

Active since

1989

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

National Institutes of Health

The University of Osaka

National Cancer Institute

Osaka City University

Tomokazu Nagano is an author at Sumitomo Dainippon Pharma (Japan) specializing in biochemistry, hepatocyte growth factor signaling, and life sciences.

Publications per year

1989–2021

Publications

Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy

Ryuichi Morishita, Shigefumi Nakamura, Shinichiro Hayashi et al. · Hypertension · 1999 · 270 citations

Medicine, Surgery, Cardiovascular Pharmacotherapy +12

The PPARα-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPARα

Qian Yang, Tomokazu Nagano, Yatrik M. Shah et al. · Toxicological Sciences · 2007 · 178 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Potential Role of Hepatocyte Growth Factor, a Novel Angiogenic Growth Factor, in Peripheral Arterial Disease : Downregulation of HGF in Response to Hypoxia in Vascular Cells

S. Hayashi, R. Morishita, Shinichiro Nakamura et al. · Circulation · 1999 · 130 citations

Life Sciences, Pathobiology, Physiology +17

Lysosomal SLC46A3 modulates hepatic cytosolic copper homeostasis

Jung-Hwan Kim, Tsutomu Matsubara, Jaekwon Lee et al. · Nature Communications · 2021 · 56 citations · Full text

Veterinary Medicine, Biochemistry, Toxicology +17

Binding Specificity ofLactobacillusto Glycolipids

Kenji Yamamoto, Takuya Miwa, Hiromu Taniguchi et al. · Biochemical and Biophysical Research Communications · 1996 · 55 citations

Life Sciences, Biochemistry, Molecular Biology +11

1–5 of 13